6533b871fe1ef96bd12d1118

RESEARCH PRODUCT

Telemedicine in the treatment of patients with inflammatory bowel disease.

Bernardo ValdiviesoJavier Del HoyoMariam AguasPilar NosRaquel Faubel

subject

medicine.medical_specialtyTelemedicine020205 medical informaticsPatient EmpowermentContext (language use)02 engineering and technologyDiseaseHealth outcomesInflammatory bowel disease03 medical and health sciences0302 clinical medicineHealth care0202 electrical engineering electronic engineering information engineeringmedicineHumansIntensive care medicineInternetbusiness.industrymedicine.diseaseInflammatory Bowel Diseasesdigestive system diseasesTelemedicineSurgeryResource use030211 gastroenterology & hepatologybusiness

description

Inflammatory bowel disease (IBD) is a chronic and relapsing disorder with significant medical, social and financial impacts. IBD patients require continuous follow-up, and healthcare resource use in this context increases over time. In the last decade, telemedicine has influenced the treatment of chronic diseases like IBD via the application of information and communication technologies to provide healthcare services remotely. Telemedicine and its various applications (telemanagement, teleconsulting and tele-education) enable closer follow-up and provide education resources that promote patient empowerment, encouraging treatment optimisation over the entire course of the disease. We describe the impact of using telemedicine on IBD health outcomes and discuss the limitations of implementing these systems in the real-life management of IBD patients.

10.1016/j.gastrohep.2017.07.001https://pubmed.ncbi.nlm.nih.gov/28797518